A.B. reports research funding to their institution from Alexion, Amgen, Arrowhead Pharmaceuticals, Eli Lilly, Ionis, NewAmsterdam Pharma and Novartis. D.J.R. reports participation in scientific advisory boards for Alnylam, Marea and Novartis, and past participation in the scientific advisory board for Verve Therapeutics.